Heparin attenuates symptoms and mast cell degranulation induced by AMP nasal provocation

Journal of Allergy and Clinical Immunology

Volumn 114, Issue 2, 2004, Pages 316-320

  Zeng, Dewan ^a   Prosperini, Gaetano ^c   Russo, Cristina ^c   Spicuzza, Lucia ^c   Cacciola, Rosella R ^c   Di Maria, Guiseppe U ^c   Polosa, Riccardo ^a,b  

^a CV Therapeutics   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c NONE

Author keywords

adenosine challenge; allergic rhinitis; Heparin; histamine; Nasal lavage fluid; NLF; tryptase

Indexed keywords

ADENOSINE PHOSPHATE; HEPARIN; HISTAMINE; TRYPTASE;

ADULT; ARTICLE; ATOPY; CELL ACTIVATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HISTAMINE RELEASE; HUMAN; IN VIVO STUDY; MALE; MAST CELL; MAST CELL DEGRANULATION; NOSE MUCUS; NOSE PROVOCATION TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SNEEZING;

ADENOSINE MONOPHOSPHATE; ADOLESCENT; ADULT; CELL DEGRANULATION; FEMALE; HEPARIN; HISTAMINE; HUMANS; MALE; MAST CELLS; NASAL MUCOSA; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; SERINE ENDOPEPTIDASES; SNEEZING; TRYPTASES;

EID: 4344652269     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2004.05.026     Document Type: Article

References (23)

1. Schwartz L.B., Bradford T.R. Regulation of tryptase from human lung mast cells by heparin. J Biol Chem. 261:1986;7372-7379
2. Sayama S., Iozzo R.V., Lazarus G.S., Schecter N.M. Human skin chymotrypsin like proteinase chymase: subcellular localization to mast cell granules and interaction with heparin and other glycosaminoglycans. J Biol Chem. 262:1987;6808-6815
3. Castellot J.J., Cochran D.L., Karnovsky M.M. Effect of heparin on vascular smooth muscle cell, I: cell metabolism. J Cell Physiol. 124:1985;21-28
4. Wright T.C., Cochran D.L., Karnovsky M.J. Inhibition of rat cervical epithelial cell growth by heparin and its reversal by EGF. J Cell Physiol. 125:1985;499-506
5. Roemisch J., Gray E., Hoffmann J.N., Wiedermann C.J. Antithrombin: a new look at the actions of a serine protease inhibitor. Blood Coagul Fibrinolysis. 13:2002;657-670
6. Okajima K. Regulation of inflammatory responses by natural anticoagulants. Immunol Rev. 184:2001;258-274
7. Bowler S.D., Smith S.M., Lavercombe P.S. Heparin inhibits the immediate response to antigen in the skin and lungs of allergic subjects. Am Rev Respir Dis. 147:1993;160-163
8. Ahmed T., Garrigo J., Danta I. Preventing bronchoconstriction in exercise-induced asthma with inhaled heparin. N Engl J Med. 329:1993;90-95
9. Polosa R., Magri S., Vancheri C., Armato F., Santonocito G., Mistretta A., et al. Time course of changes in adenosine 5′-monophosphate airway responsiveness with inhaled heparin in allergic asthma. J Allergy Clin Immunol. 99:1997;338-344
10. Page C. The role of proteoglycans in the regulation of airways inflammation and airways remodelling. J Allergy Clin Immunol. 105:2000;S518-S521
11. Lucio J., D'Brot J., Guo C.B., Abraham W.B., Lichtenstein L.M., Kagey-Sobotka A., et al. Immunologic mast cell-mediated responses and histamine release are attenuated by heparin. J Appl Physiol. 73:1992;1093-1101
12. Lee T.H., Assoufi B.K., Kay A.B. The link between exercise, respiratory heat exchange and the mast cell in bronchial asthma. Lancet. 1:1983;520-522
13. Howarth P.H., Durham S.R., Lee T.H., Kay A.B., Church M.K., Holgate S.T. Influence of albuterol, cromolyn sodium and ipratropium bromide on the airways and circulating mediator responses to antigen bronchial provocation in asthma. Am Rev Respir Dis. 132:1985;986-992
14. Spicuzza L., Bonfiglio C., Polosa R. Research applications and implications of adenosine in diseased airways. Trends Pharmacol Sci. 24:2003;409-413
15. Polosa R. Adenosine-receptor subtypes: their relevance to adenosine-mediated responses in asthma and chronic obstructive pulmonary disease. Eur Respir J. 20:2002;488-496
16. Polosa R., Pagano C., Prosperini G., Low J.L., Dokic D., Church M.K., et al. Histamine release upon adenosine 5′-monophosphate (AMP) nasal provocation in allergic subjects. Thorax. 54:1999;230-233
17. Crimi N., Polosa R., Mistretta A. Mechanisms of the effector function of adenosine in asthma and rhinitis. Drug Dev Res. 28:1993;322-327
18. Vancheri C., Mastruzzo C., Armato F., Tomaselli V., Magri S., Pistorio M.P., et al. Intranasal heparin reduces eosinophil recruitment after nasal allergen challenge in patients with allergic rhinitis. J Allergy Clin Immunol. 108:2001;703-708
19. 2-purinoceptor mediated mechanism. Biochem Pharmacol. 33:1984;3847-3852
20. Peachell P.T., Columbo M., Kagey-Sobotka A., Lichtenstein L.M., Marone G. Adenosine potentiates mediator release from human lung mast cells. Am Rev Respir Dis. 138:1988;1143-1151
21. Polosa R., Ng W.H., Crimi N., Vancheri C., Holgate S.T., Church M.K., et al. Release of mast cell-derived mediators after endobronchial adenosine challenge in asthma. Am J Respir Crit Care Med. 151:1995;624-629
22. Martinez-Salas J., Mendelssohn R., Abraham W.M., Hsiao B., Ahmed T. Inhibition of allergic airway responses by inhaled low-molecular-weight heparins: molecular-weight dependence. J Appl Physiol. 84:1998;222-228
23. Molinari J.F., Campo C., Shakir S., Ahmed T. Inhibition of antigen-induced airway hyperresponsiveness by ultralow molecular-weight heparin. Am J Respir Crit Care Med. 157:1998;887-893